top of page
  • Writer's pictureGogoa Mobility Robots

Medical innovation! Gogoa stands out at SVNCOT Annual Congress with its ambulatory exoskeletons

gogoa at svncot annual congress

Exciting news! Today we are delighted to share our remarkable day at the Annual Congress of SVNCOT - Vasco Navarro Society of Orthopedic Surgery and Traumatology, held at the Interpretation Center of La Antigua in Zumarraga.

Our CEO, Carlos Fernandez Isoird, had the honor of participating in the second roundtable, where he had the opportunity to share his perspective on exoskeletons as an innovative technology for spinal cord injuries. It was an enriching space where important advancements and solutions in the field of medicine were addressed.

At Gogoa Mobility Robots, we are committed to developing and implementing cutting-edge technologies that improve the quality of life for people with disabilities. Our exoskeletons represent a leap forward in the rehabilitation and recovery of those who have suffered spinal cord injuries, providing greater autonomy and better social integration.

During the roundtable, Carlos Fernandez Isoird shared his vision on the transformative potential of exoskeletons in rehabilitation, highlighting how this innovative technology can help restore mobility and enhance the quality of life for patients. He also emphasized the importance of collaboration between the medical sector and technology companies to drive the development of effective and accessible solutions.

We feel honored to have been part of this outstanding event and to have had the opportunity to contribute to the conversation about the future of medicine and rehabilitation. We thank SVNCOT - Vasco Navarro Society of Orthopedic Surgery and Traumatology for organizing this congress and providing us with the opportunity to share our ideas and experiences.

At Gogoa Mobility Robots, we will continue working diligently to drive research and innovation in the field of exoskeletons and other rehabilitation technologies. Our commitment is to improve people's lives, and we are eager to continue closely collaborating with the medical community and other key stakeholders to achieve significant advancements in this field.

13 views0 comments


bottom of page